Africa Medical Cannabis Market by Product Type, Distribution Channel, End User 2024-2032
                     Africa Medical Cannabis 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  la tes t  repor t  by  IMARC Group,  t i t l ed  "Afr ica  Medica l  
Cannabis  Market :  Industry  Trends,  Share ,  S ize ,  Growth ,  Opportuni ty  and 
Forecast  2024-2032,"  the  Af r i ca  med ica l  cannabis  marke t  s ize  i s  expected  
to  exh ib i t  a  growth ra te  (CAGR)  o f  19 .2% dur ing 2024-2032.
Report Cannab is  i s  a  psychoact ive  drug  tha t  i s  genera l l y  ex t rac ted f rom cannabis  
rudera l is ,  cannab is  ind ica  and cannabis  sa t iva  p lants .  I t  usua l ly  p rov ides a  
Highlight and ca lm ing  and re lax ing e f fec t  when consumed.  
There fo re ,  i t  i s  w ide ly  u t i l i zed in  the manufactu r ing  o f  var ious  medic ines  fo r  
Description the  t rea tment  o f  severa l  cond i t ions,  inc lud ing depress ion ,  insomnia ,  ch ron ic  pa in ,  anx ie ty  and  in f lammat ion.  Apar t  f rom th is ,  i t  i s  a lso  consumed by 
pa t ien ts  in  p i l l  fo rm who are  su f fe r ing  f rom acqu i red  immunodef ic iency 
syndrome (AIDS)  as  wel l  as  undergo ing  cancer  chemotherapy .
Request  for  a  PDF sample of  th is  report :  
ht tps : / /www. imarcgroup.com/a f r ica-med ica l -cannab is -marke t / reques tsample
Report Description
Afr ica  Medica l  Cannabis  Market  Trends :
The marke t  in  A f r i ca  i s  p r ima r i l y  d r i ven  by  the  r i s ing  p reva lence  o f  ch ron ic  i l l nesses  among the  masses .  A long  
w i th  th is ,  t he  inc reas ing  awareness  rega rd ing  the  med ic ina l  p roper t ies  and  bene f i t s  o f  cannab is  i s  c rea t ing  a  
pos i t i ve  ou t look  fo r  t he  marke t  ac ross  the  reg ion .  Th is  i s  suppor ted  by  the  government  in i t i a t i ves  o f  numerous  
coun t r ies  across  the  reg ion  to  lega l ize  cannab is  fa rming  in  o rder  to  u t i l i ze  i t  f o r  med ic ina l  pu rposes .  Moreover ,  
s ign i f i can t  g rowth  in  the  pharmaceu t ica l  indus t ry  ac ross  
A f r i ca  and  the  r i s ing  inves tments  by  pub l i c  and  p r iva te  f i rms  to  upgrade  the  ex is t ing  pharmaceu t ica l  sec to r  a re  
a lso  c rea t ing  a  pos i t i ve  ou t look  fo r  t he  marke t .  Apar t  f rom th i s ,  the  w idespread  adop t ion  o f  cannab is  in  the  
p repara t ion  o f  numerous  hea l th  supp lements  to  t rea t  psycho t ic  a i lmen ts  i s  p rope l l ing  the  marke t  g rowth  fu r the r .  
Some o f  the  o ther  fac to rs  con t r ibu t ing  to  the  marke t  g rowth  inc lude  ex tens ive  research  and  deve lopment  (R&D)  
ac t i v i t ies  conduc ted  by  key  p layers  in  o rde r  to  i n t roduce  e f fec t ive  p roduc t  va r ian ts  in  the  marke t .  
View Repor t  TOC,  F igures  and  Tables :  h t tps: / /www. imarcgroup.com/afr ica -medica l -cannab is -market
Breakup by Species:
• Cannabis Indica
• Sativa
• Hybrid
 
Breakup by Derivative:
Report • Cannabidiol
• Tetrahydrocannabinol
Segmentation
• Others
Breakup by Administration:
• Capsules and Oral  Solut ions
• Vaporizers
• Smoking
• Topicals
• Others
Breakup by Application:
• Cancer
Report • HIV/AIDS
• Epi lepsy
Segmentation • Pain
• Others
Breakup by End User:
• Pharmaceutical  Industry
• Research and Development Centers
• Others
Breakup by Country:
• Lesotho
Report • Zimbabwe
• South Africa
Segmentation • Ghana
• Zambia
• Malawi
• AgriPharma Pty LTD.
• Bophelo Bioscience & Wel lness (Pty) Ltd. 
(Halo Labs Inc)
Competitive • Canopy Growth Corporation
• Medigrow Afr ica
Landscape 
• Medi Kingdom
with Key • MG Health
Players • Pharmaceutical Development Company
• Precision Extract ion Solutions
• Verve Dynamics (Pty) Ltd.
How has the Africa medical cannabis market 
performed so far and how will it perform in the 
coming years?
What has been the impact of COVID-19 on the 
Africa medical cannabis market?
Key What are the key regional markets?
Questions What is the breakup of the market based on the 
species?
Answered in 
What is the breakup of the market based on the 
the Report derivative?
What is the breakup of the market based on the 
route of administration?
What is the breakup of the market based on the 
application?
What is the breakup of the market based on the 
end user?
What are the various stages in the value chain of 
the industry?
What are the key driving factors and challenges in 
the industry?
What is the structure of the Africa medical cannabis 
Key market and who are the key players?
Questions What is the degree of competition in the industry?
Answered in 
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     A f r i c a  M e d i c a l  C a n n a b i s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  S p e c i e s  
    6 . 1     C a n n a b i s  I n d i c a
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2    S a t i v a
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     H y b r i d
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  D e r i v a t i v e
       
    7 . 1     C a n n a b i d i o l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     T e t r a h y d r o c a n n a b i n o l
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     O t h e r s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  R o u t e  o f  A d m i n i s t r a t i o n
    8 . 1     C a p s u l e s  a n d  O r a l  S o l u t i o n s
Table of         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     V a p o r i z e r s
        8 . 2 . 1  M a r k e t  T r e n d s
Contents         8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     S m o k i n g
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     T o p i c a l s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     O t h e r s
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    9 . 1     C a n c e r
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /a f r i c a -med i c a l - c a nna b i s -m a rke t /
t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]